Trials / Unknown
UnknownNCT03739944
Different Surgical Approaches in Patients of Early-stage Cervical Cancer
Randomized Trial of Different Surgical Approaches in Patients of Chinese Early-stage Cervical Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- Lei Li · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center, randomized controlled study aims to compare the survival outcomes (including overall survival, progression-free survival and disease-free survival between Chinese uterine cervical patients receiving different surgical routes (laparotomy and laparoscopy) for radical hysterectomy or trachelectomy, which is the primary study objective. All patients with uterine cervical cancer of FIGO stage IA1 (with lymphovascular space invasion), IA2 and IB1 will be included and randomized into two groups: laparotomy and laparoscopy groups for radical hysterectomy or trachelectomy. Secondary study objectives include: patterns of recurrence, treatment-associated morbidity (6 months from surgery), cost-effectiveness, pelvic floor function, and quality of life.
Conditions
- Uterine Cervical Neoplasm
- Laparotomy
- Laparoscopy
- Survival
- Mortality
- Morbidity
- Quality of Life
- Pelvic Floor Disorders
- Cost-Benefit Analysis
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparotomic radical hysterectomy | Laparotomic radical hysterectomy for patients without fertility requirement |
| PROCEDURE | Laparotomic radical trachelectomy | Laparotomic radical hysterectomy for patients with fertility requirement |
| PROCEDURE | Laparoscopic radical hysterectomy | Laparoscopic radical hysterectomy for patients without fertility requirement |
| PROCEDURE | Laparoscopic radical trachelectomy | Laparoscopic radical hysterectomy for patients with fertility requirement |
Timeline
- Start date
- 2018-11-23
- Primary completion
- 2022-11-23
- Completion
- 2023-11-23
- First posted
- 2018-11-14
- Last updated
- 2018-12-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03739944. Inclusion in this directory is not an endorsement.